Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Habek

Showing results (211-220 of 251) with videos related to

Pageof 26
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 16, 2019
Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosisRichard Phelps, Jonathan A Winston, Daniel Wynn, et al.
Multiple Sclerosis and Related Disorders|July 24, 2024
Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric studyMagdalena Krbot Skorić, Vanja Bašić Kes, Nevena Grbić, et al.
Multiple Sclerosis and Related Disorders|December 11, 2025
Towards practical management of the Marburg variant of multiple sclerosisMašan Sredanović, Branka Bunoza, Ivan Lehman, et al.
Journal of Neuroimmunology|August 21, 2021
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control studyMario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, et al.
Human Mutation|February 27, 2008
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complexSonja Stahl, Sabine Gaetzner, Katrin Voss, et al.
Autonomic Neuroscience : Basic & Clinical|March 23, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
Journal of the Neurological Sciences|November 5, 2022
Transverse myelitis following COVID-19: Insights from a multi-center study and systematic literature reviewIvan Adamec, Gregor Brecl Jakob, Jelena Drulović, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|March 19, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
Lijecnicki Vjesnik|March 16, 2016
[CROATIAN GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF BENIGN PAROXYSMAL POSITIONAL VERTIGO (BPPV)]Sinisa Maslovara, Silva Butković-Soldo, Petar Drvis, et al.
Neurology and Therapy|May 3, 2022
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with OfatumumabAnne H Cross, Silvia Delgado, Mario Habek, et al.
Pageof 26

Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 16, 2019
Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosisRichard Phelps, Jonathan A Winston, Daniel Wynn, et al.
Multiple Sclerosis and Related Disorders|July 24, 2024
Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric studyMagdalena Krbot Skorić, Vanja Bašić Kes, Nevena Grbić, et al.
Multiple Sclerosis and Related Disorders|December 11, 2025
Towards practical management of the Marburg variant of multiple sclerosisMašan Sredanović, Branka Bunoza, Ivan Lehman, et al.
Journal of Neuroimmunology|August 21, 2021
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control studyMario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, et al.
Human Mutation|February 27, 2008
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complexSonja Stahl, Sabine Gaetzner, Katrin Voss, et al.
Autonomic Neuroscience : Basic & Clinical|March 23, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
Journal of the Neurological Sciences|November 5, 2022
Transverse myelitis following COVID-19: Insights from a multi-center study and systematic literature reviewIvan Adamec, Gregor Brecl Jakob, Jelena Drulović, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|March 19, 2021
Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN)Roland D Thijs, Michele Brignole, Cristian Falup-Pecurariu, et al.
Lijecnicki Vjesnik|March 16, 2016
[CROATIAN GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF BENIGN PAROXYSMAL POSITIONAL VERTIGO (BPPV)]Sinisa Maslovara, Silva Butković-Soldo, Petar Drvis, et al.
Neurology and Therapy|May 3, 2022
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with OfatumumabAnne H Cross, Silvia Delgado, Mario Habek, et al.
Pageof 26